Aristotle University Of Thessaloniki (AUTH)
Investigation of the role of RNA editing in neuronal and non-neuronal cell populations in the pathogenesis of Creutzfeldt - Jakob disease
Abstract
dc:descriptionCreutzfeldt–Jakob disease (CJD) is a rapidly progressive and fatal prion disease characterised by synaptic dysfunction, neuronal injury, glial activation, and marked molecular heterogeneity. Although prion-seeding assays have improved diagnostic evaluation, complementary molecular readouts that reflect disease stage, molecular subtype, and cell-specific pathological processes, including those detectable in peripheral samples, remain needed. RNA editing is a co/post-transcriptional regulatory mechanism that can influence RNA processing, stability, coding potential, cellular stress responses, and innate immune signalling. However, its contribution to neuronal and myeloid-cell responses during prion-associated neurodegeneration remains insufficiently defined.The present thesis examines RNA editing across neuronal, microglial, and peripheral myeloid populations relevant to CJD, integrating cellular and animal models of prion disease with human CJD brain tissue and ALS-Ox frontal cortex as a comparative neurodegenerative proteinopathy model. This framework evaluates editing alterations in relation to cellular identity, disease progression, molecular subtype, cross-species conservation, and peripheral biomarker potential.A comparative analysis of published single-cell RNA-sequencing datasets examined the transcriptional relationship between disease-associated microglia and late-response, inflammatory-associated, and proliferative-region-associated microglial states. Disease-associated microglia showed partial transcriptional overlap with these populations, particularly with late-response microglia, while retaining distinct signatures associated with neurodegeneration. By distinguishing disease-associated microglial programmes from inflammatory and proliferative states, this comparison provides the biological context for interpreting stage-dependent RNA editing changes in CJD microglia and their relationship to neuroimmune remodelling during disease progression.In chronically scrapie-infected neuronal cells, prion infection was associated with increased global RNA editing and altered editing of transcripts involved in synaptic organisation, intracellular trafficking, RNA localisation, and neuroimmune signalling. APOBEC1 depletion markedly reduced global editing and predominantly decreased editing of transcripts related to synaptic organisation, RNA and protein transport, proteostasis, and cellular stress. Consistently, APOBEC1-deficient mice reached terminal disease earlier after RML prion challenge and showed a more pronounced late-stage decline in body weight.In ALS-Ox frontal cortex human brain studies, reduced global RNA editing converged on glutamatergic synapse-related transcripts, including altered editing of GRIK2 and experimentally validated editing changes in CACNA1C, indicating that synapse-associated editing dysregulation may extend beyond prion disease and represent a recurrent molecular feature of neurodegenerative proteinopathies.Longitudinal analysis of CD11b-enriched microglia from hu-sCJD Tg340 mice revealed marked stage-dependent remodelling of RNA editing. Early disease was characterised by immune-regulatory transcriptional changes with limited global editing disruption, whereas preclinical microglia showed increased editing in the absence of broad transcriptional alterations. The clinical stage exhibited the largest expansion of predominantly intronic, ADAR-associated editing, affecting targets related to synaptic organisation and neuronal connectivity. At terminal disease, the number of detectable RNA editing sites was markedly reduced, alongside transcriptional signatures of innate immune activation, cellular stress, and proteostatic dysfunction.Human CJD brain analyses further demonstrated subtype-dependent editing profiles. MM1/MV1 cases showed extensive ADAR-mediated editing, redistribution towards intronic and Alu-associated sites, and synapse-centred differentially edited targets. In contrast, VV2 cases displayed a smaller and functionally distinct signature associated with RNA metabolism, repetitive-element regulation, protein turnover, and cellular stress. The strongest cross-species overlap was identified between clinical-stage Tg340 microglia and human MM1 CJD brain. FGF14 emerged as a recurrent editing candidate across Tg340 disease stages, human MM1 CJD brain, and terminal-stage peripheral macrophages.Overall, the present work identifies RNA editing as a dynamic molecular layer linking neuronal dysfunction, synaptic vulnerability, and neuroimmune responses during prion disease. The partial overlap between editing targets identified in microglia and peripheral macrophages further indicates that aspects of the central disease-associated editome may be reflected in accessible peripheral immune-cell populations. These findings provide a framework for future studies assessing RNA editing signatures as complementary tools for CJD molecular characterisation, patient stratification, and disease monitoring, while also supporting investigation of RNA editing mechanisms as potential targets for therapeutic intervention.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karagianni, Korina-Maria
- Καραγιάννη, Κορίνα-Μαρία
Subjects
dc:subject × 21- RNA στοιχειοθεσία
- Νόσος Creutzfeldt–Jakob
- Πριονικές νόσοι
- Μικρογλοία
- Νευροεκφυλισμός
- Νευροφλεγμονή
- Βιοδείκτες
- RNA editing
- Creutzfeldt–Jakob disease
- Prion diseases
- Microglia
- Neurodegeneration
- Neuroinflammation
- Biomarkers
- Transcriptomics
- Βιολογία
- Φυσικές Επιστήμες
- Βιοχημεία και Μοριακή βιολογία
- Biological Sciences
- Natural Sciences
- Biochemistry and Molecular Biology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62897